Role of CD14 in hemorrhagic shock-induced alterations of the monocyte tumor necrosis factor response to endotoxin

Journal of Trauma - Injury, Infection and Critical Care

Volumn 40, Issue 4, 1996, Pages 564-567

  Nwariaku, Fiemu ^a   Sikes, Pat ^a   Lightfoot, Ellis ^a   McIntyre, Kendra ^a   Mileski, William J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD14; Cytokine; Hypovolemic; Inflammation; Monocyte; Shock

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; DOSE RESPONSE; HEMORRHAGIC SHOCK; HYPOVOLEMIA; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RABBIT;

EID: 0029984605     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199604000-00007     Document Type: Article

References (16)

1. Ayala A, Perrin MM, Ertel W, Chaudry IH: Differential effects of hemorrhage on Kupffer cells: Decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 4:66, 1992
2. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH: Hemorrhage induces an increase in serum TNF which is not associated with increased levels of endotoxin. Cytokine 2:170, 1990
3. Stephan RN, Conrad PJ, Janeway CA, Geha S, Baue AE, Chaudry IH: Decreased interleukin-2 production following simple hemorrhage. Surg Forum 37:73, 1986
4. Shenkar R, Abraham E: Effects of hemorrhage on cytokine gene transcription. Lymphokine Cytokine Res 12:237, 1993
5. Stephan RN, Conrad PJ, Janeway CA, Geha S, Baue AE, Chaudry IH: Hemorrhage without significant tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 122:62, 1987
6. Ayala A, Perrin MM, Wagner MA, Chaudry IH: Enhanced susceptibility to sepsis following simple hemorrhage: Depression of Fc and C3b receptor mediated phagocytosis. Arch Surg 125:70, 1990
7. Ulevitch R, Mathison J, Schumann R, Tobias P: A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma 30 suppl.:S189, 1990
8. Desch et al: Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res 8:141, 1989
9. Ugolini V, Nunez G, Smith G, Stastny P, Capra D: Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci USA 77:6764, 1980
10. Flick DA, Gifford GE: Comparison of in vitro cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167, 1984
11. Beutler B, Cerami A: The biology of cachectin/TNF - A primary mediator of the host response. Ann Rev Immunol 7:625, 1989
12. Darling G, Boldstein DS, Stoll R, Groschboth CM, Norton JA: Tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Surgery 106:1155, 1989
13. Schirmer WJ, Schimer JM, Fry DE: Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg 124:445, 1989
14. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark TV, Hariri RJ, Fahey TJ, III, Zewntella A, Albert JD, Shires GR, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470, 1993
15. Tobias P, Soldau K, Ulevitch R: Isolation of a lipopolysaccharide-binding acute-phase reactant from rabbit serum. J Exp Med 164:777, 1986
16. Wright DS: CD14 and innate recognition of bacteria. J Immunol 155:6, 1995